Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.00
Bid: 26.00
Ask: 28.00
Change: -0.50 (-1.82%)
Spread: 2.00 (7.692%)
Open: 27.50
High: 27.50
Low: 27.00
Prev. Close: 27.50
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Contract Renewals and Grant Award

30 Jul 2013 07:00

RNS Number : 4024K
Ilika plc
30 July 2013
 



Ilika plc

("Ilika" or the "Company")

 

Contract Renewals and Grant Award

 

Ilika plc (AIM: IKA), the advanced cleantech materials discovery company, announces the renewal of two commercial contracts with existing Japanese corporate customers and a grant award from the UK's Technology Strategy Board ("TSB").

 

Contract Renewals

The first contract renewal is with a leading automotive OEM for the further development of battery materials for electric and hybrid vehicle applications. The second is with a diversified electronics and industrial OEM looking to exploit Ilika's Intellectual Property within the healthcare sector. These two contract renewals represent revenue of approximately £320,000 to be recognised in the current financial year.

 

TSB Award

Ilika has also received a grant award from the UK's TSB worth £64,000 to support the commercialisation of a polymer material developed by the Company, following successful evaluation by key opinion leaders and potential licensing partners, within the healthcare sector.

 

These contract renewals and grant award, in aggregate with existing contracts, increase the company's level of committed revenues for the current financial year to approximately £535,000, which is more than double the level of committed revenue achieved at this point last financial year.

 

Commenting on the contract renewals, Graeme Purdy, CEO of Ilika, said, "These contracts represent a solid start to this financial year and demonstrate the Company's ability to retain its core customers. Whilst Asia continues to be our key geographical market on which our growth is founded, we are also making progress is attracting new customers in Europe and North America."

 

 

For more information contact:

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Numis Securities Limited

Tel: 020 7260 1000

Oliver Cardigan, Nominated Adviser

 

James Black, Corporate Broking

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780

Paul McManus

Mob: 07980 541 893 or ilika@walbrookpr.com

Paul Cornelius

Mob: 07827 879 460 or ilika@walbrookpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCNKCDPPBKDFOB
Date   Source Headline
2nd Dec 20134:16 pmRNSHolding(s) in Company
12th Nov 20137:00 amRNSHalf Year Trading Update
28th Oct 20137:00 amRNSIlika expands into Aerospace Sector
21st Oct 20137:00 amRNSInvestor Teach-in
17th Sep 20134:09 pmRNSResult of AGM
17th Sep 20137:00 amRNSAGM Statement
16th Sep 20137:00 amRNSTwo New Customers in Europe
23rd Aug 20131:25 pmRNSPosting of Annual Report & Notice of AGM
2nd Aug 20135:02 pmRNSConversion of Securities
30th Jul 20137:00 amRNSContract Renewals and Grant Award
19th Jul 20132:50 pmRNSHolding(s) in Company
19th Jul 201311:17 amRNSHolding(s) in Company
18th Jul 20137:00 amRNS£3.3 million EPSRC Grant Award to Southampton Univ
15th Jul 20137:00 amRNSFinal Results
21st May 20131:09 pmRNSHolding(s) in Company
20th May 20137:00 amRNSDirectorate Change and Conversion of Securities
17th May 20133:57 pmRNSPlacing - Replacement
17th May 20137:00 amRNSPlacing
1st May 20137:00 amRNSFuel Cell Catalyst Patent Granted in Japan
22nd Apr 20137:00 amRNSContract with new European Customer
16th Apr 20137:00 amRNSTrading Update
21st Feb 20137:00 amRNSRenewal of Contract
29th Jan 20137:00 amRNSCompletion of Laboratory Facility Expansion
18th Jan 20133:28 pmRNSHolding(s) in Company
17th Jan 20135:46 pmRNSHolding(s) in Company
17th Jan 201311:16 amRNSHolding(s) in Company
15th Jan 20135:21 pmRNSHolding(s) in Company
10th Jan 20137:00 amRNSInterim Results
21st Dec 20127:00 amRNSGrant of Fuel Cell Catalyst Patent
18th Dec 20121:41 pmRNSCompletion of Disposal
17th Dec 20127:00 amRNSConversion of Securities
11th Dec 20127:00 amRNSRenewal of Contract
29th Nov 20124:44 pmRNSHolding(s) in Company
28th Nov 20125:00 pmRNSHolding(s) in Company
27th Nov 20122:18 pmRNSHolding(s) in Company
19th Nov 20127:00 amRNSEnergizer Relationship Update
22nd Oct 20127:00 amRNSTrading Update
5th Oct 20127:00 amRNSHolding(s) in Company
5th Oct 20127:00 amRNSTotal Voting Rights
18th Sep 20127:00 amRNSDiscontinuing of wound care products and services
14th Sep 20127:00 amRNSCarbon Trust Investment
7th Sep 20121:27 pmRNSResult of AGM
7th Sep 20127:00 amRNSAGM Statement
9th Aug 20127:00 amRNSPosting of Annual Report & Notice of AGM
19th Jul 20127:00 amRNSFinal Results
14th Jun 20127:14 amRNSChange of Adviser
1st Jun 201210:01 amRNSTotal Voting Rights
18th May 20127:00 amRNSTrading Update
17th May 20127:00 amRNSConversion of Securities
2nd May 20127:00 amRNSVapour Deposition Method US Patent Grant

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.